Michael Vicchiarelli

Statistics

Publications

Citations

625

H-Index

Active since

2009

Affiliations

Sanford Burnham Prebys Medical Discovery Institute(Current)

University of Florida

Institute for Learning Innovation

Florida College

University of Kansas

Michael Vicchiarelli is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2009–2021

Publications

Discovery and Validation of a Series of Aryl Sulfonamides as Selective Inhibitors of Tissue-Nonspecific Alkaline Phosphatase (TNAP)

Russell Dahl, Eduard Sergienko, Ying Su et al. · Journal of Medicinal Chemistry · 2009 · 104 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor

Patrick Maloney, Pasha M. Khan, Michael Hedrick et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 62 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy

Kevin J. Frankowski, Michael P. Hedrick, Palak Gosalia et al. · ACS Chemical Neuroscience · 2012 · 56 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB Activation

Pasha M. Khan, Ricardo G. Correa, Daniela Divlianska et al. · ACS Medicinal Chemistry Letters · 2011 · 54 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Discovery of ML314, a Brain Penetrant Nonpeptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor

Satyamaheshwar Peddibhotla, Michael P. Hedrick, Paul Hershberger et al. · ACS Medicinal Chemistry Letters · 2013 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 17